PYRIDINE COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS

The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.

Saved in:
Bibliographic Details
Main Authors KISS, Gert, GILL, Adrian, AAY, Naing, MELLEM, Kevin, SEMKO, Christopher, BUCKL, Andreas, KOLTUN, Elena S
Format Patent
LanguageEnglish
Published 21.03.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.
Bibliography:Application Number: US202318138917